You are consulting for a clinical research group planning a trial to compare survival rates for proposed and standard cancer treatments. The planned data analysis is a log-rank test to nonparametrically compare the overall survival curves for the two treatments. Your goal is to determine an appropriate sample size to achieve a power of 0.8 for a two-sided test with = 0.05 by using a balanced design.
The survival curve for patients on the standard treatment is well known to be approximately exponential with a median survival time of five years. The research group conjectures that the new proposed treatment will yield a (nonexponential) survival curve similar to the dashed line in Figure 70.6.1.
Patients will be accrued uniformly over two years and then followed for an additional three years past the accrual period. Some loss to follow-up is expected, with roughly exponential rates that would result in about 50% loss with the standard treatment within 10 years. The loss to follow-up with the proposed treatment is more difficult to predict, but 50% loss would be expected to occur sometime between years 5 and 20.
Use the TWOSAMPLESURVIVAL statement with the TEST=LOGRANK option to compute the required sample size for the log-rank test. The following statements perform the analysis:
proc power; twosamplesurvival test=logrank curve("Standard") = 5 : 0.5 curve("Proposed") = (1 to 5 by 1):(0.95 0.9 0.75 0.7 0.6) groupsurvival = "Standard" | "Proposed" accrualtime = 2 followuptime = 3 groupmedlosstimes = 10 | 20 5 power = 0.8 npergroup = .; run;
The CURVE= option defines the two survival curves. The "Standard" curve has only one point, specifying an exponential form with a survival probability of 0.5 at year 5. The "Proposed" curve is a piecewise linear curve defined by the five points shown in Figure 70.6.1. The GROUPSURVIVAL= option assigns the survival curves to the two groups, and the ACCRUALTIME= and FOLLOWUPTIME= options specify the accrual and follow-up times. The GROUPMEDLOSSTIMES= option specifies the years at which 50% loss is expected to occur. The POWER= option specifies the target power, and the NPERGROUP=. option identifies sample size per group as the parameter to compute. Default values for the SIDES= and ALPHA= options specify a two-sided test with = 0.05.
Output 70.6.2 shows the results.
Fixed Scenario Elements | |
---|---|
Method | Lakatos normal approximation |
Accrual Time | 2 |
Follow-up Time | 3 |
Group 1 Survival Curve | Standard |
Form of Survival Curve 1 | Exponential |
Group 2 Survival Curve | Proposed |
Form of Survival Curve 2 | Piecewise Linear |
Group 1 Median Loss Time | 10 |
Nominal Power | 0.8 |
Number of Sides | 2 |
Number of Time Sub-Intervals | 12 |
Alpha | 0.05 |
Computed N Per Group | |||
---|---|---|---|
Index | Median Loss Time 2 |
Actual Power | N Per Group |
1 | 20 | 0.800 | 228 |
2 | 5 | 0.801 | 234 |
The required sample size per group to achieve a power of 0.8 is 228 if the median loss time is 20 years for the proposed treatment. Only six more patients are required in each group if the median loss time is as short as five years.